Skip to main content

Tocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse events

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Tocilizumab looks promising for corticosteroid refractory anti-PD-1-related adverse events

User login

Username

Password

Reset your password

Type	Lead	score